x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Molecule to Market: Inside the outsourcing space

Molecule to Market takes you inside the contract outsourcing space with industry insights and thoughts direct from the brains of the people that make the headlines. Talking everything from pharmaceutical contract research, development and manufacturing to clinical trial packaging, logistics and technology – Molecule to Market is a vital shot of infotainment for anyone who wants in on outsourcing.

science life sciences

All Episodes

52:48

Meet the healthcare futurist

Molecule to Market: Inside the outsourcing space ·

2025/02/07

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Imran Kausar, Founder of DeepHealth Consulting.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Imran, covering: His unusual blend of experience led to a road into big pharma... Switching the security of Big Pharma to join an exciting, scrappy, start-up biotech... before an exit to Roche Being part of the gene therapies evolution with an

en

54:00

The dynamic duo driving global growth

Molecule to Market: Inside the outsourcing space ·

2025/01/31

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with James Lovett, CEO and Mike Cohen, Executive Chairman at Myonex.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with James and Mike, covering: How a family-owned pharmacy became a major global clinical trial supplies business... two generations later Mike's decision to bring in a CEO and the challenge of letting go... before seeing the data

en

39:44

Biopharma Insights: Live from J.P. Morgan

Molecule to Market: Inside the outsourcing space ·

2025/01/24

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Dean McAlister, Executive Vice President at Inizio Biotech.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Dean, covering: The evolving dynamics within the life sciences sector and how they are shaping outsourcing strategies Key insights and trends from J.P. Morgan week, including challenges and opportunities for CROs and CDMOs The

en

54:23

The CEO making a global impact

Molecule to Market: Inside the outsourcing space ·

2025/01/17

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Peter DeYoung, CEO at Piramal Global Pharma.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Peter, covering: Why did Peter fall in love with the pharma sector? Why did he decide to leave McKinsey and jump into PE? The value of living and working in different places, and why you should jump at the chance if you ever get the opportunity to

en

45:07

2024 reflections and 2025 outlook in pharma services

Molecule to Market: Inside the outsourcing space ·

2025/01/10

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Ian Tzeng, a Managing Director and Partner in L.E.K. Consulting.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Ian, covering: Reflections on 2024's market dynamics, shifting sponsor behavior, big pharma woes, biotech rebound and segment-specific impact The outlook for 2025 across discovery, development, clinical trials, and

en

45:48

From questions to answers: Celebrating 200 episodes

Molecule to Market: Inside the outsourcing space ·

2025/01/03

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Raman Sehgal, Founder & Global President at ramarketing & Host of Molecule to Market.For this milestone episode, your host is Molecule to Market’s first guest from back in 2020, JoyL Silva, Customer Engagement Lead for the US Primary Care portfolio at Pfizer, who discusses the pharmaceutical and biotechnology supply chain with Raman Sehgal covering: Raman reflects on

en

52:25

Charles River's lifelong CDMO leader

Molecule to Market: Inside the outsourcing space ·

2024/12/13

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Kerstin Dolph, Senior Vice President of Manufacturing at Charles River Laboratories.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Kerstin, covering: The value of having managers and mentors guide you and champion your success Navigating transitions from finance to operations and research to biologics manufacturing while becoming a

en

51:23

The pharma ingredients disruptor

Molecule to Market: Inside the outsourcing space ·

2024/12/06

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jack Stine, Chief Executive Officer at Savendor.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Jack, covering: What he learned about supplier relationship management from exposure to 70 supply chain sourcing teams in 3M The shift to sourcing APIs and excipients for generics and med devices under FDA regulations How he always wanted to

en

55:28

Baking success to IQVIA exit

Molecule to Market: Inside the outsourcing space ·

2024/11/29

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Tessa Pugh, ex-CEO & Co-Founder at PharmaReview.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Tessa, covering: How Tessa's bullish attitude led to her becoming a co-founder at PharmaReview Being the 'less educated person in the office', and using that to drive the growth of the business Opting not to leave after the sale of the

en

52:00

The biotech-MedTech CEO tackling obesity

Molecule to Market: Inside the outsourcing space ·

2024/11/22

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Dr Camilla Easter, CEO at Oxford Medical Products.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Camilla, covering: Training long and hard as a Veterinary Surgeon surgeon... and then deciding to pivot into biotech Falling in love with the freedom and excitement of a start-up biotech while learning the importance of problem-solving and

en

56:54

Delhi boy, done good

Molecule to Market: Inside the outsourcing space ·

2024/11/15

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Akshay Peer, co-founder and Senior Vice President of Products at TrakCel.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Akshay, covering: How the development of a patent led him into the CGT space—years before it was a market The founding story of TrakCel and getting GSK as an anchor client to support early iterations of its custom

en

55:20

Meet the Top Gun CDMO Maverick

Molecule to Market: Inside the outsourcing space ·

2024/11/08

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with John Fowler, President & CEO at Pii (Pharmaceutics International, Inc.)Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with John, covering: How a competitive family environment and navigating flight school in the Navy equipped him for a successful career Why a CDMO business is like managing chaos... under strict regulations The silver

en

58:28

Pfizer's retired manufacturing veteran

Molecule to Market: Inside the outsourcing space ·

2024/11/01

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Peter Stevenson, Independent Director and Pharma industry veteran. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Peter, covering: Bringing an outsourcing model from UpjohnPharmacia into Pfizer and then driving manufacturing out of Pfizer into CDMOs without compromising on quality or IP Behind the scenes of Pfizer's mammoth acquisitions

en

19:26

Tasty Topics: Navigating Novo Nordisk’s Acquisition...

Molecule to Market: Inside the outsourcing space ·

2024/10/25

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with:Dirk Lange, CEO at Pyramid Labs Brett Alderson, President & Site Leader at NovaCina John Cameron, Director, Global Injectables Platform at Corden Pharma Janet Hoogstraate, CEO at NorthX Biologics Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Dirk, Brett, John & Janet, focusing on: Maximizing GLP-1 manufacturing capacity:

en

57:59

Reimagining drug development

Molecule to Market: Inside the outsourcing space ·

2024/10/18

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jen Nwankwo, Founder and CEO at 1910 Genetics.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Jen, covering: Being the first PHD at Bain's Global HQ, and what she learned from the experience How she stumbled across AI and open innovation as it applied to R&D productivity, and accelerating clinical trials The founding story of 1910,

en

50:50

A lifetime of drug hunting

Molecule to Market: Inside the outsourcing space ·

2024/10/11

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Karen Lackey, CEO at X-Chem.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Karen, covering: Why diversity of thought is essential in solving problems that have never been solved before Why did she leave the big pharma world after 30 years to join the world of academia? And how joining a global CRO enabled Karen to democratize its tech

en

58:22

The pink-haired CEO

Molecule to Market: Inside the outsourcing space ·

2024/10/04

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Emma Banks, CEO at ramarketing. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Emma Banks, CEO at ramarketing, covering: How a conversation with her late father led Emma to look out for herself and jump into the unknown The contrast of two different CEO roles - stepping from a hand-to-mouth cash-strapped tech business into a rapid-growth

en

49:55

The Harvard spin-out disrupting drug discovery

Molecule to Market: Inside the outsourcing space ·

2024/09/27

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Rani Powers, Founder & CEO at Pluto Bio.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Rani, covering: Her passion for coding and what drew her into the world of biology How the frustration of using clunky software in the lab led to the exploration of a better alternative... and eventually her own start-up The value of continuous

en

45:35

The rare disease champion

Molecule to Market: Inside the outsourcing space ·

2024/09/20

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Tamar Thompson, Head of Global Corporate Affairs at Alexion, AstraZeneca Rare Disease.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology space with Tamar, covering: The epidemiological challenge of rare diseases and representing the topic at the White House Why is rare disease drug development so hard, but why is there so much interest in the area given the

en

58:18

The VC Biotech investor

Molecule to Market: Inside the outsourcing space ·

2024/09/13

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Chris Garabedian, CEO at Xontogeny and Venture Fund Manager at Perceptive Advisors.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Chris, covering: How he utilized his pharma experience to become a CEO and revitalize a biotech company, positioning it for a $15bn market cap Why the biotech space had such a market downturn, and how the

en

246 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter